Literature DB >> 33269940

Computed tomography characteristics of multiple myeloma and other osteolytic metastatic bone lesions.

Uygar Mutlu1, Ali Balci1, Güner Hayri Özsan2, Sermin Özkal3, Ahmet Şeyhanli2, Hakan Abdullah Özgül1.   

Abstract

BACKGROUND: Differentiation of multiple myeloma (MM) from osteolytic metastatic (OM) bone lesions may be critical in patients with lytic bone lesions but can be challenging for radiologists.
PURPOSE: To determine whether computed tomography (CT) can be used to distinguish between MM and other OM bone lesions.
MATERIAL AND METHODS: In this retrospective study, 320 lesions of 207 patients diagnosed with MM or OM, based on biopsy or clinical examination, were evaluated. Eight qualitative features were evaluated by two radiologists blinded to the diagnoses. The chi-square and Fisher exact tests, and logistic regression analysis, were used to evaluate the relationships between the CT findings and diagnoses.
RESULTS: High-density areas were more common in OM than MM lesions (85.2% and 19%, P < 0.001), as were perilesional sclerosis (38.9% vs. 13.2%, P < 0.001), heterogeneity (on non-contrast CT images, 60% vs. 19.1%, P < 0.001; on contrast enhanced CT images, 80.6% vs. 28.2%, P < 0.001), and ill-defined margins (34.6% vs. 9.1%, P < 0.001). Similarly, OM lesions showed high-density areas more than MM in evaluation of skeletal system subgroups (vertebrae, 93.8% vs. 29.8%, P < 0.0001; thoracic cage bones, 69.6% vs. 19.2%, P < 0.001; pelvic bones and sacrum, 84.8% vs. 7.7%, P < 0.001; peripheral skeletal bones, 81.5% vs. 8.3%, P < 0.001). Logistic regression analysis revealed that the presence of a high-density area in the lesion increased the probability of a metastasis 25.88-fold (R2 = 0.516, P < 0.001).
CONCLUSION: MM and OM lesions can be differentiated by CT; OM lesions exhibit high- density areas.

Entities:  

Keywords:  Multiple myeloma; computed tomography; computed tomography characteristics; osteolytic metastatic bone lesions

Mesh:

Substances:

Year:  2020        PMID: 33269940     DOI: 10.1177/0284185120977035

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

Review 1.  What's new in the management of metastatic bone disease.

Authors:  Shinji Tsukamoto; Costantino Errani; Akira Kido; Andreas F Mavrogenis
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-10-13

Review 2.  Quantitative Imaging and Radiomics in Multiple Myeloma: A Potential Opportunity?

Authors:  Alberto Stefano Tagliafico; Alida Dominietto; Liliana Belgioia; Cristina Campi; Daniela Schenone; Michele Piana
Journal:  Medicina (Kaunas)       Date:  2021-01-21       Impact factor: 2.430

3.  Differentiating Between Multiple Myeloma and Metastasis Subtypes of Lumbar Vertebra Lesions Using Machine Learning-Based Radiomics.

Authors:  Xing Xiong; Jia Wang; Su Hu; Yao Dai; Yu Zhang; Chunhong Hu
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

4.  Application of 18F-FDG PET-CT Images Based Radiomics in Identifying Vertebral Multiple Myeloma and Bone Metastases.

Authors:  Zhicheng Jin; Yongqing Wang; Yizhen Wang; Yangting Mao; Fang Zhang; Jing Yu
Journal:  Front Med (Lausanne)       Date:  2022-04-18

5.  Intraosseous schwannoma in the clivus mimicking chordoma treated with endoscopic endonasal surgery: A case report.

Authors:  Takaaki Ishikawa; Hiroyoshi Akutsu; Takuma Hara; Shuho Tanaka; Tomohiko Masumoto; Eiichi Ishikawa
Journal:  Surg Neurol Int       Date:  2022-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.